FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2566074419> ?p ?o ?g. }

• W2566074419 endingPage "851" @default.
• W2566074419 startingPage "847" @default.
• W2566074419 abstract "Carfilzomib is a second-generation tetrapeptide epoxyketone proteasome inhibitor used in current clinical therapy of hematologic malignancies. The mechanism of proteasome inhibition in endometrial cancer is not very clear. Carfilzomib inhibition of type I endometrial carcinoma cell proliferation by inducing cell cycle arrest at the G2/M phase was investigated in our study. HEC-1-A and Ishikawa endometrial carcinoma cell lines and three tumor cell lines were treated by different concentrations of carfilzomib. Methyl thiazolyl tetrazolium (MTT) assay was used to detect cell viability. Flow cytometry was used to analyze the cell cycle. Western blot was used to detect proteins involved in cell cycle progression. Carfilzomib impaired viability of myelogenous leukemia cell line K562, cervical cancer cell line HeLa, hepatocellular carcinoma cell line SMCC-7721, and endometrial carcinoma cell lines HEC-1-A and Ishikawa. The cell cycle was arrested at the G2/M phase in carfilzomib-treated HEC-1-A endometrial carcinoma cells, while it was arrested at both S and G2/M phases in carfilzomib-treated Ishikawa cells. Carfilzomib treatment significantly induced p21Waf1/ Cip1 and p27, while substantially reduced cyclin D3 and cyclin-dependent kinase 1. This study showed that carfilzomib inhibited endometrial cancer proliferation by upregulating cyclin-dependent kinase inhibitors p21Waf1/Cip1 and p27Kip1, and reducing cyclin-dependent kinase 1 to arrest the cell cycle at the G2/M phase." @default.
• W2566074419 created "2017-01-06" @default.
• W2566074419 creator A5000255298 @default.
• W2566074419 creator A5001346768 @default.
• W2566074419 creator A5046294611 @default.
• W2566074419 creator A5073347540 @default.
• W2566074419 creator A5076091833 @default.
• W2566074419 date "2016-12-01" @default.
• W2566074419 modified "2023-10-16" @default.
• W2566074419 title "Carfilzomib induces G2/M cell cycle arrest in human endometrial cancer cells via upregulation of p21Waf1/Cip1 and p27Kip1" @default.
• W2566074419 cites W1840141254 @default.
• W2566074419 cites W189122563 @default.
• W2566074419 cites W1970001436 @default.
• W2566074419 cites W1995092890 @default.
• W2566074419 cites W1998738134 @default.
• W2566074419 cites W2004008931 @default.
• W2566074419 cites W2018397421 @default.
• W2566074419 cites W2037992356 @default.
• W2566074419 cites W2047901396 @default.
• W2566074419 cites W2079950665 @default.
• W2566074419 cites W2083565407 @default.
• W2566074419 cites W2108767279 @default.
• W2566074419 cites W2121619780 @default.
• W2566074419 cites W2131817855 @default.
• W2566074419 cites W2139141601 @default.
• W2566074419 cites W2163553489 @default.
• W2566074419 cites W2168790441 @default.
• W2566074419 cites W2170552969 @default.
• W2566074419 cites W2305470812 @default.
• W2566074419 cites W2313783489 @default.
• W2566074419 cites W2341751972 @default.
• W2566074419 cites W2343423203 @default.
• W2566074419 cites W2356921328 @default.
• W2566074419 cites W4210989197 @default.
• W2566074419 doi "https://doi.org/10.1016/j.tjog.2016.09.003" @default.
• W2566074419 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28040131" @default.
• W2566074419 hasPublicationYear "2016" @default.
• W2566074419 type Work @default.
• W2566074419 sameAs 2566074419 @default.
• W2566074419 citedByCount "12" @default.
• W2566074419 countsByYear W25660744192017 @default.
• W2566074419 countsByYear W25660744192018 @default.
• W2566074419 countsByYear W25660744192019 @default.
• W2566074419 countsByYear W25660744192020 @default.
• W2566074419 countsByYear W25660744192021 @default.
• W2566074419 countsByYear W25660744192022 @default.
• W2566074419 crossrefType "journal-article" @default.
• W2566074419 hasAuthorship W2566074419A5000255298 @default.
• W2566074419 hasAuthorship W2566074419A5001346768 @default.
• W2566074419 hasAuthorship W2566074419A5046294611 @default.
• W2566074419 hasAuthorship W2566074419A5073347540 @default.
• W2566074419 hasAuthorship W2566074419A5076091833 @default.
• W2566074419 hasBestOaLocation W25660744191 @default.
• W2566074419 hasConcept C105696609 @default.
• W2566074419 hasConcept C121608353 @default.
• W2566074419 hasConcept C126322002 @default.
• W2566074419 hasConcept C25311885 @default.
• W2566074419 hasConcept C2776364478 @default.
• W2566074419 hasConcept C2777366897 @default.
• W2566074419 hasConcept C2778367456 @default.
• W2566074419 hasConcept C2780108899 @default.
• W2566074419 hasConcept C29537977 @default.
• W2566074419 hasConcept C502942594 @default.
• W2566074419 hasConcept C53227056 @default.
• W2566074419 hasConcept C54355233 @default.
• W2566074419 hasConcept C71924100 @default.
• W2566074419 hasConcept C81885089 @default.
• W2566074419 hasConcept C86803240 @default.
• W2566074419 hasConceptScore W2566074419C105696609 @default.
• W2566074419 hasConceptScore W2566074419C121608353 @default.
• W2566074419 hasConceptScore W2566074419C126322002 @default.
• W2566074419 hasConceptScore W2566074419C25311885 @default.
• W2566074419 hasConceptScore W2566074419C2776364478 @default.
• W2566074419 hasConceptScore W2566074419C2777366897 @default.
• W2566074419 hasConceptScore W2566074419C2778367456 @default.
• W2566074419 hasConceptScore W2566074419C2780108899 @default.
• W2566074419 hasConceptScore W2566074419C29537977 @default.
• W2566074419 hasConceptScore W2566074419C502942594 @default.
• W2566074419 hasConceptScore W2566074419C53227056 @default.
• W2566074419 hasConceptScore W2566074419C54355233 @default.
• W2566074419 hasConceptScore W2566074419C71924100 @default.
• W2566074419 hasConceptScore W2566074419C81885089 @default.
• W2566074419 hasConceptScore W2566074419C86803240 @default.
• W2566074419 hasIssue "6" @default.
• W2566074419 hasLocation W25660744191 @default.
• W2566074419 hasLocation W25660744192 @default.
• W2566074419 hasLocation W25660744193 @default.
• W2566074419 hasOpenAccess W2566074419 @default.
• W2566074419 hasPrimaryLocation W25660744191 @default.
• W2566074419 hasRelatedWork W1969042084 @default.
• W2566074419 hasRelatedWork W1991423165 @default.
• W2566074419 hasRelatedWork W2123536860 @default.
• W2566074419 hasRelatedWork W2352662618 @default.
• W2566074419 hasRelatedWork W2374592133 @default.
• W2566074419 hasRelatedWork W2913551689 @default.
• W2566074419 hasRelatedWork W2995944259 @default.
• W2566074419 hasRelatedWork W3043721042 @default.
• W2566074419 hasRelatedWork W4253005196 @default.

• next